We conducted a systematic review and meta-analysis to determine the risk of neuropsychiatric adverse events and death in all published placebo controlled randomised controlled trials of varenicline. This review deals with some of the limitations of the previous studies and is the most comprehensive published review to date of the neuropsychiatric safety of varenicline.
